Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Emerging terbinafine resistance in Trichophyton: clinical characteristics, squalene epoxidase gene mutations and a reliable EUCAST method for detection.

Saunte DML, Hare RK, Jørgensen KM, Jørgensen R, Deleuran M, Zachariae CO, Thomsen SF, Bjørnskov-Halkier L, Kofoed K, Arendrup MC.

Antimicrob Agents Chemother. 2019 Aug 5. pii: AAC.01126-19. doi: 10.1128/AAC.01126-19. [Epub ahead of print]

PMID:
31383665
2.

EUCAST reference testing of rezafungin susceptibility: impact of choice of plastic plates.

Arendrup MC, Jørgensen KM, Hare RK, Cuenca-Estrella M, Zaragoza O.

Antimicrob Agents Chemother. 2019 Jul 8. pii: AAC.00659-19. doi: 10.1128/AAC.00659-19. [Epub ahead of print]

PMID:
31285230
3.

Comprehensive functional profiling of long non-coding RNAs through a novel pan-cancer integration approach and modular analysis of their protein-coding gene association networks.

Walters K, Sarsenov R, Too WS, Hare RK, Paterson IC, Lambert DW, Brown S, Bradford JR.

BMC Genomics. 2019 Jun 3;20(1):454. doi: 10.1186/s12864-019-5850-7.

4.

Would you like to purchase a rodent with dermatophytes?

Tekin HG, Sigsgaard V, Zachariae C, Hare RK, Arendrup MC, Saunte DML.

Mycoses. 2019 Jul;62(7):584-587. doi: 10.1111/myc.12923. Epub 2019 May 22.

PMID:
31050372
5.

EUCAST Susceptibility Testing of Isavuconazole: MIC Data for Contemporary Clinical Mold and Yeast Isolates.

Jørgensen KM, Astvad KMT, Hare RK, Arendrup MC.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00073-19. doi: 10.1128/AAC.00073-19. Print 2019 Jun.

6.

In Vivo Selection of a Unique Tandem Repeat Mediated Azole Resistance Mechanism (TR120) in Aspergillus fumigatus cyp51A, Denmark.

Hare RK, Gertsen JB, Astvad KMT, Degn KB, Løkke A, Stegger M, Andersen PS, Kristensen L, Arendrup MC.

Emerg Infect Dis. 2019 Mar;25(3):577-580. doi: 10.3201/eid2503.180297.

7.

Implications of the EUCAST Trailing Phenomenon in Candida tropicalis for the In Vivo Susceptibility in Invertebrate and Murine Models.

Astvad KMT, Sanglard D, Delarze E, Hare RK, Arendrup MC.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01624-18. doi: 10.1128/AAC.01624-18. Print 2018 Dec.

8.

Isavuconazole in a Successful Combination Treatment of Disseminated Mucormycosis in a Child with Acute Lymphoblastic Leukaemia and Generalized Haemochromatosis: A Case Report and Review of the Literature.

Pomorska A, Malecka A, Jaworski R, Radon-Proskura J, Hare RK, Nielsen HV, Andersen LO, Jensen HE, Arendrup MC, Irga-Jaworska N.

Mycopathologia. 2019 Feb;184(1):81-88. doi: 10.1007/s11046-018-0287-0. Epub 2018 Jul 23. Review.

PMID:
30039238
9.

EUCAST Determination of Olorofim (F901318) Susceptibility of Mold Species, Method Validation, and MICs.

Jørgensen KM, Astvad KMT, Hare RK, Arendrup MC.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00487-18. doi: 10.1128/AAC.00487-18. Print 2018 Aug.

10.

[Diagnosing and treating of onychomycosis].

Tolstrup J, Jemec GB, Hare RK, Arendrup MC, Saunte DM.

Ugeskr Laeger. 2018 May 14;180(20). pii: V10170785. Review. Danish.

PMID:
29761779
11.

Update from a 12-Year Nationwide Fungemia Surveillance: Increasing Intrinsic and Acquired Resistance Causes Concern.

Astvad KMT, Johansen HK, Røder BL, Rosenvinge FS, Knudsen JD, Lemming L, Schønheyder HC, Hare RK, Kristensen L, Nielsen L, Gertsen JB, Dzajic E, Pedersen M, Østergård C, Olesen B, Søndergaard TS, Arendrup MC.

J Clin Microbiol. 2018 Mar 26;56(4). pii: e01564-17. doi: 10.1128/JCM.01564-17. Print 2018 Apr.

12.

Evaluation of the in vitro activity of isavuconazole and comparator voriconazole against 2635 contemporary clinical Candida and Aspergillus isolates.

Astvad KMT, Hare RK, Arendrup MC.

Clin Microbiol Infect. 2017 Nov;23(11):882-887. doi: 10.1016/j.cmi.2017.03.023. Epub 2017 Apr 1.

Supplemental Content

Support Center